NEFSG - Fabry Overview Diagnosis 
Home
Fabry Overview
Disease Inheritance
Clinical Symptoms
Atypical Variant Forms
Diagnosis
Physician Information
Female Patients
Children and Adolescents
Your Family Tree
Treatment Options
Fabry Registry
Supportive Links
Fabry Handouts
Announcements
Ask a Patient
Ask a Doctor
Financial Questions
Treatment Centers
Glossary
Contact Us
Fabry Overview - Diagnosis

The diagnosis of Fabry disease needs to be made as early as possible to help prevent painful and debilitating symptoms and permit patients and their families the appropriate medical care. Delayed diagnosis is often due to under recognition of the disease.

The clinical diagnosis can be based upon the presence of the cardinal Fabry symptoms or through a family history; a history of a family member, such as a maternal uncle or grandfathers who died early due to renal failure, a heart attack or stroke could also be a strong indicator.

The symptoms to look for:

In adolescents or younger adults:
___ pain in the extremities associated with fevers
___ exercise intolerance with the inability to sweat
___ abdominal pain and diarrhea after eating
___ red to purple colored skin legions in the bathing suit area

In later years:
___ proteinuria or renal failure due to unknown reasons
___ strokes in a relatively young person with unclear etiology
___ left ventricular hypertrophy or cardiomyopathy in the absence of high blood pressure

Diagnosis is confirmed in males with a simple blod test for enzyme assay measuring the functional level of alpha galactosidase A enzyme. This test will disclose affected males but it is not reliable for detection of females. Lyonization will affect the interpretation of the AGAL due to the fact that different cells throughout the body will produce different amounts of the enzyme. Therefore, for female patients, a DNA sequence analysis is the most precise procedure to confirm the diagnosis. For patients with unknown causes for renal failure or LVH, a tissue biopsy is a simple procedure and a confirmatory test.